AHA yesterday submitted policy recommendations to House Ways and Means Committee leaders as they begin developing Medicare-related legislation to address the opioid crisis. The committee is seeking feedback on specific questions related to overprescribing, data tracking, beneficiary notification, provider education, and treatment options. AHA also has submitted recommendations to other committees of jurisdiction, as Congress plans to enact comprehensive legislation on opioids this spring. 

Related News Articles

Headline
Update: The Senate passed the measure by a vote of 71-29.The Senate Jan. 30 is expected to pass a government funding plan ahead of a midnight deadline. A…
Headline
The AHA Jan. 28 released its 2026 Advocacy Agenda, containing the association’s key priorities for Congress, the administration, regulatory agencies and courts…
Headline
A KFF analysis released Jan. 28 found that Medicare Advantage insurers made nearly 53 million prior authorization determinations in 2024, an increase…
Headline
The Centers for Medicare & Medicaid Services Jan. 26 released proposed changes to Medicare Advantage plan capitation rates and Part D payment policies for…
Headline
The AHA Jan. 26 expressed support and provided its perspective on certain provisions within the Centers for Medicare & Medicaid Services’ proposed…
Headline
The AHA Jan. 20 made recommendations to Congress on modernizing the Medicare Access and CHIP Reauthorization Act. Among the proposals, the AHA recommended…